Guide to Canine and Feline Electrocardiography 2018
DOI: 10.1002/9781119254355.ch17
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐arrhythmic Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 50 publications
0
3
0
Order By: Relevance
“…Similarly, the relatively large number of respondents who used lidocaine and sotalol could be explained by the fact that ventricular tachycardia was the fourth most diagnosed arrhythmia in this study. Both sotalol and lidocaine are described a first‐line treatment for ventricular tachycardia 17 . We also tried to speculate a few potential reasons why amiodarone, mexiletine, magnesium and esmolol were used so infrequently.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, the relatively large number of respondents who used lidocaine and sotalol could be explained by the fact that ventricular tachycardia was the fourth most diagnosed arrhythmia in this study. Both sotalol and lidocaine are described a first‐line treatment for ventricular tachycardia 17 . We also tried to speculate a few potential reasons why amiodarone, mexiletine, magnesium and esmolol were used so infrequently.…”
Section: Discussionmentioning
confidence: 99%
“…We also tried to speculate a few potential reasons why amiodarone, mexiletine, magnesium and esmolol were used so infrequently. For example, amiodarone is considered a second‐line drug for atrial fibrillation 16 and ventricular arrhythmias 17 . Mexiletine has availability issues in Europe and is expensive for long‐term treatment.…”
Section: Discussionmentioning
confidence: 99%
“…peak plasma level sotalol two to four hours after oral intake in humans) and the onset of SCD 55 minutes after attaching the Holter ECG, it is debatable whether oral administration of antiarrhythmic drugs prior to Holter ECG monitoring could have potentially reduced VA burden, or prevented SCD during Holter in this cat (Hanyok, 1993). Besides, whilst antiarrhythmic drugs have been shown to reduce VA burden in some cases, studies in veterinary medicine have generally failed to show any reduction in the occurrence of SCD (Mac-Donald et al, 2011;da Silva, 2018). A continuous rate infusion of lidocaine or esmolol might have reduced VA frequency during Holter ECG (Verschoor-Kirss et al, 2022).…”
Section: Discussionmentioning
confidence: 99%